Scholarlink

Background <p>Persistent somatic symptoms (PSS) that occur in various somatic, functional, or mental health conditions can lead to considerable psychological distress and functional impairment. As such, they are a key characteristic of the Somatic Symptom Disorder (SSD) in DSM-5. While psychological treatments such as cognitive behavioral approaches can address these symptoms, their clinical efficacy in reducing symptom burden in previous trials remains limited. Blended psychotherapy, i.e., combining face-to-face psychotherapy with digital elements, is a promising new approach to efficiently enhance psychotherapeutic effects. This study therefore aims to evaluate the efficacy, mechanisms, and safety of blended psychotherapy compared to enhanced standard psychotherapy for individuals with SSD in outpatient psychotherapy.</p> Methods <p>A two-armed, multicenter randomized controlled&#xa0;pragmatic trial will be conducted, and <i>N</i> = 250 adults with SSD will be randomized to either blended psychotherapy (20 individual sessions of cognitive behavioral therapy (CBT) + accompanying digital intervention; iSOMA+) or enhanced CBT (20 sessions of CBT + self-help booklet; CBT+). Participants are recruited at eight German university outpatient psychotherapy clinics. Assessments will be conducted at patient study inclusion (pre-treatment), during treatment, post-treatment, and 6&#xa0;months follow-up. The primary outcome is the reduction in somatic symptom severity using the Screening for Somatoform Disorders (SOMS-7R) from baseline to post-treatment. Secondary outcomes include changes in symptom-related distress, coping, self-efficacy, as well as depression, anxiety, health anxiety, disability, quality of life, interpersonal relationship experiences and patient safety. Additionally, several potential moderators and mediators, including patient and intervention characteristics, will be examined.</p> Discussion <p>This trial investigates the potential of blended CBT for improving treatment outcomes in patients with SSD and&#xa0;will provide evidence on the effects of active vs. passive self-help as treatment augmentation&#xa0;under pragmatic care conditions. By identifying prescriptive factors of treatment response, the study will support personalized care and contribute to more accessible and efficacious treatment options for patients with PSS.</p> Trial registration <p>German Clinical Trials Register (DRKS) DRKS00035250. Registered on 13.06.2025, <a href="https://drks.de/search/de/trial/DRKS00035250">https://drks.de/search/de/trial/DRKS00035250</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy of blended digital and face-to-face psychotherapy compared to enhanced psychotherapy for patients with Somatic Symptom Disorder (iSOMA+): study protocol for a multicenter randomized controlled pragmatic trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月10日

查看全文
  • Freda Kristine Jutzi,
  • Michael Witthöft,
  • Harald Baumeister,
  • Mira Denninger,
  • Winfried Rief,
  • Gaby Bleichhardt,
  • Josef Bailer,
  • Peter Kirsch,
  • Maja Halli-Erkic,
  • Daniela Mier,
  • Mara Mankin,
  • Julia A. Glombiewski,
  • Rabea Vogt,
  • Jens Heider,
  • Frank Jacobi,
  • Alexandra Martin,
  • Barbara Schulte-Holthausen,
  • Kai Kronfeld,
  • Stanislav Gorbulev,
  • Christian Ruckes,
  • Rüdiger Pryss,
  • Robin Kraft,
  • Severin Hennemann

摘要

Background

Persistent somatic symptoms (PSS) that occur in various somatic, functional, or mental health conditions can lead to considerable psychological distress and functional impairment. As such, they are a key characteristic of the Somatic Symptom Disorder (SSD) in DSM-5. While psychological treatments such as cognitive behavioral approaches can address these symptoms, their clinical efficacy in reducing symptom burden in previous trials remains limited. Blended psychotherapy, i.e., combining face-to-face psychotherapy with digital elements, is a promising new approach to efficiently enhance psychotherapeutic effects. This study therefore aims to evaluate the efficacy, mechanisms, and safety of blended psychotherapy compared to enhanced standard psychotherapy for individuals with SSD in outpatient psychotherapy.

Methods

A two-armed, multicenter randomized controlled pragmatic trial will be conducted, and N = 250 adults with SSD will be randomized to either blended psychotherapy (20 individual sessions of cognitive behavioral therapy (CBT) + accompanying digital intervention; iSOMA+) or enhanced CBT (20 sessions of CBT + self-help booklet; CBT+). Participants are recruited at eight German university outpatient psychotherapy clinics. Assessments will be conducted at patient study inclusion (pre-treatment), during treatment, post-treatment, and 6 months follow-up. The primary outcome is the reduction in somatic symptom severity using the Screening for Somatoform Disorders (SOMS-7R) from baseline to post-treatment. Secondary outcomes include changes in symptom-related distress, coping, self-efficacy, as well as depression, anxiety, health anxiety, disability, quality of life, interpersonal relationship experiences and patient safety. Additionally, several potential moderators and mediators, including patient and intervention characteristics, will be examined.

Discussion

This trial investigates the potential of blended CBT for improving treatment outcomes in patients with SSD and will provide evidence on the effects of active vs. passive self-help as treatment augmentation under pragmatic care conditions. By identifying prescriptive factors of treatment response, the study will support personalized care and contribute to more accessible and efficacious treatment options for patients with PSS.

Trial registration

German Clinical Trials Register (DRKS) DRKS00035250. Registered on 13.06.2025, https://drks.de/search/de/trial/DRKS00035250.